Diabetes
News
Inflammatory markers may explain COVID-19, diabetes dynamic
Higher levels of markers may signal greater susceptibility to cytokine storm.
News
Dapagliflozin trial in CKD halted because of high efficacy
An independent data monitoring committee recommended stopping the trial.
News
Larger absolute rivaroxaban benefit in diabetes: COMPASS
News
Keep calm: Under 25s with diabetes aren't being hospitalized for COVID-19
But some are concerned that type 1 diabetes diagnoses are being delayed.
News
FDA advises stopping SGLT2 inhibitor treatment prior to surgery
The changes affect canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, and were made because surgery may put patients taking SGLT2...
News
Treating COVID-19 in patients with diabetes
Most health advisories about COVID-2019 mention diabetes as one of the high-risk categories for the disease.
News
COVID-19: Extra caution needed for patients with diabetes
Coexisting heart disease, kidney disease, advanced age, and frailty are likely to further increase the severity of disease.
News
Risk factors for death from COVID-19 identified in Wuhan patients
The odds of dying in the hospital increased with age, higher SOFA score, and D-dimer level exceeding 1 mcg/L.
News
MACE benefits with dapagliflozin improve with disease duration
Findings suggest treatment with the SGLT-2 inhibitor should be initiated early in some high-risk patients.
News
Tools for preventing heart failure
SNOWMASS, COLO. – “There will be more than 1 million new cases of heart failure this year, and the vast majority of them could have been prevented...